The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin: Contribution to selective retention of lipoprotein(a) in atherosclerotic lesions

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1687, Issue 1-3, 2005, Pages 1-10

  D'Angelo, Angela ^a   Geroldi, Diego ^a   Hancock, Mark A ^b   Valtulina, Viviana ^a   Cornaglia, Antonia I ^a   Spencer, Craig A ^b   Emanuele, Enzo ^a   Calligaro, Alberto ^a   Koschinsky, Marlys L ^b   Speziale, Pietro ^a   Visai, Livia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Apolipoprotein(a); Atherosclerosis; Laminin; Lipoprotein(a)

Indexed keywords

AMINOCAPROIC ACID; APOLIPOPROTEIN A; APOLIPOPROTEIN B100; IODINE 125; ISOPROTEIN; LAMININ; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; RECOMBINANT PROTEIN;

ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT;

EID: 13644262152     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2004.10.005     Document Type: Article

References (39)

1. S. Pillarisetti, L. Paka, J.C. Obunike, L. Berglund, and I.J. Goldberg Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix J. Clin. Invest. 100 1997 867 874
2. A.M. Scanu, K. Nakajima, and C. Edelstein Apolipoprotein(a): structure and biology Front. Biosci. 6 2001 D546 D554
3. Y.Y. Van der Hoek, W. Sangrar, G.P. Côté, J.J.P. Kastelein, and M.L. Koschinsky Binding of recombinant apolipoprotein(a) to extracellular matrix proteins Arterioscler. Thromb. 14 1994 1792 1798
4. M.N. Rahman, L. Becker, V. Petrounevitch, B.C. Hill, Z. Jia, and M.L. Koschinsky Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10 Biochemistry 41 2002 1149 1155
5. J. Xia, L.F. May, and M.L. Koschinsky Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity J. Lipid Res. 41 2000 1578 1584
6. B.R. Gabel, L.F. May, S.M. Marcovina, and M.L. Koschinsky Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation Arterioscler. Thromb. Vasc. Biol. 16 1996 1559 1567
7. A. de la Pena-Diaz, R. Izaguirre-Avila, and E. Angles-Cano Lipoprotein Lp(a) and atherothrombotic disease Arch. Med. Res. 31 2000 353 359
8. G. Lippi, and G. Guidi Lipoprotein(a): an emerging cardiovascular risk factor Crit. Rev. Clin. Lab. Sci. 40 2003 1 42
9. M.A. Hancock, M.B. Boffa, S.M. Marcovina, M.E. Nesheim, and M.L. Koschinsky Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces J. Biol. Chem. 278 2003 23260 23269
10. E. Angles-Cano, A. de la Pena Diaz, and S. Loyau Inhibition of fibrinolysis by lipoprotein(a) Ann. N.Y. Acad. Sci. 936 2001 261 275
11. U. Lundstam, E. Hurt-Camejo, G. Olsson, P. Sartipy, G. Camejo, and O. Wiklund Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix Arterioscler. Thromb. Vasc. Biol. 19 1999 1162 1167
12. A.C. Liu, and R.M. Lawn Vascular interactions of lipoprotein(a) Curr. Opin. Lipidol. 5 1994 269 273
13. O. Klezovitch, C. Edelstein, L. Zhu, and A.M. Scanu Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin. Implications for the retention of lipoprotein(a) in atherosclerotic lesions J. Biol. Chem. 273 1998 23856 23865
14. P.V. LoGrasso, S. Cornell-Kennon, and B.R. Boettcher Cloning, expression, and characterization of human apolipoprotein(a) kringle IV37 J. Biol. Chem. 269 1994 21820 21827
15. X. Chenivesse, T. Huby, J. Wickins, J. Chapman, and J. Thillet Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57→Asn mutation in kringle IV-10 is associated with poor fibrin binding Biochemistry 37 1998 7213 7223
16. N.W. Boonmark, X.J. Lou, Z.J. Yang, K. Schwartz, J.L. Zhang, and E.M. Rubin Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice J. Clin. Invest. 100 1997 558 564
17. S.D. Hughes, and E.M. Rubin Vascular accumulation of Lp(a): in vivo analysis of the role of lysine-binding sites using recombinant adenovirus Clin. Genet. 52 1997 361 366
18. E.M. Salonen, M. Jauhiainen, L. Zardi, A. Vaheri, and C. Ehnhlom Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it EMBO J. 8 1989 4035 4040
19. J. Labat-Robert, E. Gruber, and M. Bihari-Varga Interaction between fibronectin, proteoglycans and lipoproteins Int. J. Biol. Macromol. 12 1990 50 54
20. H. Colognato, and P.D. Yurchenco Form and function: the laminin family of heterotrimers Dev. Dyn. 218 2000 213 234
21. J.T. Willerson, and P. Zoldhelyi Future directions in thrombolysis Clin. Cardiol. 22 1999 IV44 IV53
22. M. Vuento, and A. Vaheri Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions Biochem. J. 183 1979 331 337
23. E. Strawich, and M.E. Nimmi Properties of a collagen molecule containing three identical components extracted from bovine articular cartilage Biochemistry 10 1971 3905 3911
24. C. Kang, M. Dominguez, S. Loyau, T. Miyata, V. Durlach, and E. Angles-Cano Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody Arterioscler. Thromb. Vasc. Biol. 22 2002 1232 1238
25. B.J. Davis Disc electrophoresis: II. Method and application to human serum proteins Ann. N.Y. Acad. Sci. 121 1964 404 427
26. D. Geroldi, V. Bellotti, P. Buscaglia, G. Bonetti, C. Gazzaruso, A. Caprioli, and P. Fratino Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population sample Clin. Chim. Acta 221 1993 159 169
27. M.L. Koschinsky, J.E. Tomlison, T.F. Zioncheck, K. Schwartz, D.L. Eaton, and R.M. Lawn Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells Biochemistry 30 1991 5044 5051
28. G.A. Keesler, B.R. Gabel, C.M. Devlin, M.L. Koschinsky, and I. Tabas The binding activity of the macrophage lipoprotein(a)/apolipoprotein(a) receptor is induced by cholesterol via a post-translational mechanism and recognizes distinct kringle domains on apolipoprotein(a) J. Biol. Chem. 271 1996 32096 32104
29. W. Sangrar, B.R. Gabel, M.B. Boffa, J.B. Walker, M.A. Hancock, S.M. Marcovina, A.J.G. Horrevoets, M.E. Nesheim, and M.L. Koschinsky The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface Biochemistry 36 1997 10353 10363
30. B.R. Gabel, and M.L. Koschinsky Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100 Biochemistry 37 1998 7892 7898
31. G. Köhler, and C. Milstein Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
32. L. Visai, Y. Xu, F. Casolini, S. Rindi, M. Höök, and P. Speziale Monoclonal antibodies to CNA, a collagen-binding microbial surface component recognizing adhesive matrix molecules, detach Staphylococcus aureus from a collagen substrate J. Biol. Chem. 275 2000 39837 39845
33. N.M. Caplice, C. Panetta, T.E. Peterson, L.S. Kleppe, C.S. Mueske, G.M. Kostner, G.J. Broze Jr., and R.D. Simari Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis Blood 98 2001 2980 2987
34. S.M. Hsu, L. Raine, and H. Fanger A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies Am. J. Clin. Pathol. 75 1981 734 738
35. S.M. Hsu, L. Raine, and H. Fanger Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures J. Histochem. Cytochem. 29 1981 577 580
36. T. Soulat, S. Loyau, V. Baudouin, L. Maisonneuve, M.F. Hurtaud-Roux, N. Schlegel, C. Loirat, and E. Angles-Cano Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: an in vitro study using plasma from children with idiopathic nephrotic syndrome Arterioscler. Thromb. Vasc. Biol. 20 2000 575 584
37. J. Kreuzer, M.B. Lloyd, D. Bok, G.M. Fless, A.M. Scanu, A.J. Lusis, and M.E. Haberland Lipoprotein(a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall Chem. Phys. Lipids 67/68 1994 175 190
38. G.M. Kostner, and M. Bihari-Varga Is the atherogenicity of Lp(a) caused by its reactivity with proteoglycans? Eur. Heart J. 11 1990 184 189
39. S. Kochl, F. Fresser, E. Lobentanz, G. Baier, and G. Utermann Novel interaction of apolipoprotein(a) with beta-2 glycoprotein I mediated by the kringle IV domain Blood 90 1997 1482 1489